Yuen M-F, Wong D K-H, Zheng B-J, Chan C C-S, Yuen J C-H, Wong B C-Y, Lai C-L
Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong, China.
J Viral Hepat. 2007 Apr;14(4):269-75. doi: 10.1111/j.1365-2893.2006.00799.x.
The underlying mechanisms for earlier hepatitis B e antigen (HBeAg) seroconversion in patients with chronic hepatitis B virus (HBV) genotype B when compared with genotype C are unknown. We aimed to determine whether there were any differences in the T helper (Th) responses during hepatitis flares in HBeAg-positive patients with genotypes B and C. Proliferative response measured by (3)H-thymidine uptake and Th responses measured by Enzyme-Linked Immunosorbent Spot assays for interleukin (IL)-2, interferon-gamma (IFN-gamma), IL-4, IL-5 and IL-10 were performed in 10 patients with genotype B and 10 with genotype C with hepatitis flares. HBV genotypes, core promoter, precore mutations, sequence of HBV core region and HBV DNA levels were determined. There was no difference in the HBV DNA levels during hepatitis flares between patients with genotypes B and C. Patients with genotype B had a significantly higher number of IFN-gamma producing cells [with hepatitis B core antigen (HBcAg) stimulation] and lower number of IL-10 producing cells (with HBcAg and HBeAg stimulation) compared with patients with genotype C (P = 0.011, =0.043, <0.001 respectively). There was a trend (P = 0.058) that patients with genotype B had a higher cumulative rate of HBeAg seroconversion. Patients with precore mutants also had a significantly higher number of IFN-gamma producing cells (with HBcAg stimulation) and lower number of IL-10 producing cells (with HBeAg stimulation) compared to patients without precore mutant (P = 0.038, =0.016 respectively). HBV genotype B induces a greater Th1 and lesser Th2 response than genotype C. This provides immunologic evidence for the higher chance of HBeAg seroconversion in patients with genotype B.
与C基因型慢性乙型肝炎病毒(HBV)患者相比,B基因型患者乙肝e抗原(HBeAg)血清学转换更早的潜在机制尚不清楚。我们旨在确定B和C基因型HBeAg阳性患者肝炎发作期间辅助性T细胞(Th)反应是否存在差异。对10例B基因型和10例C基因型肝炎发作患者进行了通过³H-胸腺嘧啶核苷摄取测量的增殖反应以及通过酶联免疫斑点法检测白细胞介素(IL)-2、干扰素-γ(IFN-γ)、IL-4、IL-5和IL-10的Th反应。测定了HBV基因型、核心启动子、前核心突变、HBV核心区域序列和HBV DNA水平。B和C基因型患者肝炎发作期间的HBV DNA水平无差异。与C基因型患者相比,B基因型患者产生IFN-γ的细胞数量显著更多(乙肝核心抗原(HBcAg)刺激时),产生IL-10的细胞数量更少(HBcAg和HBeAg刺激时)(P分别为0.011、0.043、<0.001)。B基因型患者HBeAg血清学转换的累积率有升高趋势(P = 0.058)。与无前核心突变患者相比,前核心突变患者产生IFN-γ的细胞数量也显著更多(HBcAg刺激时),产生IL-10的细胞数量更少(HBeAg刺激时)(P分别为0.038、0.016)。与C基因型相比,HBV B基因型诱导更强的Th1反应和较弱的Th2反应。这为B基因型患者HBeAg血清学转换机会更高提供了免疫学证据。